Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design

Abstract

Twenty-nine Amaryllidaceae alkaloids and their derivatives belonging to the five most common groups, including lycorine, lycorenine, tazettine, crinine, and narciclasine types, were evaluated for antiproliferative, apoptosis–inducing, and anti-invasive activities in vitro. The antiproliferative properties of each test compound are in agreement with those reported in the literature, while the high potency of amarbellisine is reported for the first time. It was also found that with the exception of ungeremine, amarbellisine, and hippeastrine, the antiproliferative effect of the potent compounds is apoptosis mediated. Thus, apoptosis in Jurkat cells was triggered by narciclasine, narciclasine tetraacetate, C10b-R-hydroxypancratistatin, cis-dihydronarciclasine, trans-dihydronarciclasine, lycorine, 1-O-acetyllycorine, lycorine-2-one, pseudolycorine, and haemanthamine. With the exception of narciclasine, lycorine, and haemanthamine, the apoptosis-inducing properties of these compounds are reported for the first time. The collagen type I invasion assay revealed potent anti-invasive properties associated with N-methyllycorine iodide, hippeastrine, clivimine, buphanamine, and narciclasine tetraacetate, all of which were tested at non-toxic concentrations. The anti-invasive activity of buphanamine is particularly promising because this alkaloid is not toxic to cells even at much higher doses. This work has resulted in the identification of several novel leads for anticancer drug design.

Key words

Amaryllidaceae - alkaloid - apoptosis - invasion - drug lead

References

• 1 Newman D J, Cragg G M, Snader K M. Natural products as sources of new drugs over the period 1981–2002.  J Nat Prod. 2003;  66 1022-1037
• 2 Hartwell J L. Plants used against cancer. A survey.  Lloydia. 1967;  30 379
• 3 Gardeil J B. Traduction des Oeuvres Médicales d'Hippocrate. Toulouse; Fages, Meilhec et Cie 1801 (4 vols)
• 4 Martin S F. The alkaloids. New York; Academic Press 1987: 251
• 5 Gibbs R D. Chemotaxonomy of flowering plants. Vol. III. Montreal; McGill-Queen's University Press 1974: 1924
• 6 Tojo E. (+)-Narcidine, a new alkaloid from Nacissus pseudonarcissus.  J Nat Prod. 1991;  54 1387-1388
• 7 Noumbissie B E, Kapnang H, Fomum Z T, Martin M T, Bodo B. The myristicaeae of Cameroon. 1. Staudtienic acid, a diterpene from Staudtia kamerunesis.  J Nat Prod. 1992;  55 137-139
• 8 Bastida J, Codina C, Viladomat F, Rubiralta M, Quirion J C, Weniger B. Narcissus alkaloids. 14. (+)-8-O-acetylhomolycorine and vasconine, 2 novel alkaloids from Narcissus vasconicus.  J Nat Prod. 1992;  55 122-125
• 9 Plinius Secundus C. Natural history, translated by J. Bostock and H. T. Riley. London; Bohn 1855 (6 vols)
• 10 Hartwell J L. Plants used against cancer. Lawrencee, Massachusetts; Quarterman Publication 1982
• 11 Kosteletzky B F. Allgemeine medizinisch-pharmazeutische Flora. Prag; Borrosch and André 1831–1836 6 vols
• 12 Hoshino O. The Amarillidaceae alkaloids. Cordell GA The alkaloids. Vol. 51. London; Academic Press 1998: 323-376
• 13 Cook J W, Loudon J D. The alkaloids. New York; Academic Press 1952: 331
• 14 Carrasco L, Fresno M, Vazquez D. Narciclasine: an antitumor alkaloid which blocks peptide bond formation by eukaryotic ribosomes.  FEBS Lett. 1975;  52 236-239
• 15 Jimenez A, Sanchez L, Vazquez D. Location of resistance to the alkaloid narciclasine in the 60S ribosomal subunit.  FEBS Lett. 1975;  55 53-56
• 16 Jimenez A, Santos A, Alonso G, Vasquez D. Inhibitors of protein synthesis in eukariotic cells. Comparative effects of some Amaryllidaceae alkaloids.  Biochim Biophys Acta. 1976;  425 342-348
• 17 Kornienko A, Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners.  Chem Rev. 2008;  108 1982-2014
• 18 Vial J P, Belloc F, Dumain P, Besnard S, Lacombe F, Boisseau M R, Reiffers J, Bernard P. Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells.  Leuk Res. 1997;  21 163-172
• 19 Zhang H Z, Kasibhatla S, Kuemmerle J, Kemnitzer W, Ollis-Mason K, Qiu L, Crogan-Grundy C, Tseng B, Drewe J, Cai S X. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.  J Med Chem. 2005;  48 5215-5223
• 20 Kemnitzer W, Kasibhatla S, Jiang S, Zhang H, Zhao J, Jia S, Xu L, Crogan-Grundy C, Denis R, Barriault N, Vaillancourt L, Charron S, Dodd J, Attardo G, Labrecque D, Lamothe S, Gourdeau H, Tseng B, Drewe J, Cai S X. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions.  Bioorg Med Chem Lett. 2005;  15 4745-4751
• 21 Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, Jia S, Herich J, Labreque D, Storer R, Meerovitch K, Bouffard D, Rej R, Denis R, Blais C, Lamothe S, Attardo G, Gourdeau H, Tseng B, Kasibhatla S, Cai S X. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.  J Med Chem. 2004;  47 6299-6310
• 22 Ferrara N, Kerbel R S. Angiogenesis as a therapeutic target.  Nature. 2005;  438 967-974
• 23 Dickinson R B, Johnson M D, Maemura M, Low J. Anti-invasion drugs.  Breast Cancer Res Treat. 1996;  38 121-132
• 24 Hirota K, Semenza G L. Regulation of angiogenesis by hypoxia-inducible factor 1.  Crit Rev Oncol Hematol. 2006;  59 15-26
• 25 Khasig P Z, Pdobed O V, Gracheva T S, Salbiev K D, Grachev S V, Brezov T T. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.  Biochem Moscow. 2003;  68 711-717
• 26 Evidente A, Iasiello I, Randazzo G. An improved method for the large-scale preparation of lycorine.  Chem Ind. 1984;  348-349
• 27 Evidente A. Narciclasine: ¹H and ¹³C‐NMR data and a new improved method of preparation.  Planta Med. 1991;  57 293-295
• 28 Evidente A, Andolfi A, Abou-Donia A H, Touema S M, Hammoda H M, Shawsky E, Motta A. (−)-Amarbellisine, a lycorine-type alkaloid from Amaryllis belladona L. growing in Egypt.  Phytochemistry. 2004;  65 2113-2118
• 29 Evidente A, Abou-Donia A H, Darwish F A, Amer M E, Kassem F F, Hammoda H AM. Nobilisitines A and B, two masanane-type alkaloids from Clivia nobilis.  Pytochemistry. 1999;  51 1151-1155
• 30 Evidente A, Andolfi A, Abou-Donia A H, Darwish F A, Hammoda H AM, Motta A. Minor alkaloids from Clivia nobilis Regel.  Alex J Pharm Sci. 2005;  19 49-53
• 31 Abou-Donia A H, Abib A A, El Din A S, Evidente A, Gaber M, Scopa A. Two betaine-type alkaloids from bulbs of Pancratium maritimum.  Phytochemistry. 1992;  31 2139-2141
• 32 Evidente A, Cicala M R, Randazzo G, Riccio R, Calabrese G, Liso R, Arrigoni O. Lycorine structure-activity relationships.  Phytochemistry. 1983;  22 2192-2196
• 33 Evidente A, Arrigoni O, Liso R, Calabrese G, Randazzo G. Further experiments on lycorine-structure-activity relationships among the lycorine alkaloids.  Phytochemistry. 1986;  25 2739-2743
• 34 Mondon A, Krohn K. Chemistry of narciclasine.  Chem Berlin. 1975;  108 445-463
• 35 Pettit G R, Melody N, O'Sullivan M, Thompson M A, Herald D L, Coates B. Synthesis of B‐10-R-hydroxypancratistatin via narciclasine.  J Chem Soc Chem Commun. 1994;  2725-2726
• 36 Pettit G R, Melody N, Herald D L, Schmidt J M, Pettit R K, Chapuis J C. Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1,2-diepipancratistatin and related isocarbostyrils.  Heterocycles. 2002;  56 139-155
• 37 Mosmann T. Rapid colorimetric assay for cellular growth and survival – application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63
• 38 Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis – flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin-V.  J Immunol Methods. 1995;  184 39-51
• 39 Pettit G R, Pettit I IIGR, Backhaus R A, Boyd M R, Meerow A W. Antineoplastic agents, 256. Cell growth inhibitory isocarbostylis from Hymenocallis.  J Nat Prod. 1993;  56 1682-1687
• 40 Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, Kiss R. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.  Neoplasia. 2007;  9 766-776
• 41 Weniger B, Italiano L, Beck J P, Bastida J, Bergonon S, Codina C, Lobstein A, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids.  Planta Med. 1995;  61 77-79
• 42 Hohmann J, Forgo P, Molnar J, Wolfard K, Molnar A, Thalhammer T, Máthé I, Sharples D. Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis.  Planta Med. 2002;  68 454-457
• 43 Barthelmes H U, Niederberger E, Roth T, Schulte K, Tang W C, Boege F, Fiebig H H, Eisenbrand G, Marko D. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.  Br J Cancer. 2001;  85 1585-1591
• 44 Liu J, Hu W X, He L F, Ye M, Li Y. Effects of lycorine on HL‐60 cells via arresting cell cycle and inducing apoptosis.  FEBS Lett. 2004;  578 245-250
• 45 Li Y, Liu J, Tang L J, Shi Y W, Ren W, Hu W X. Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest.  Oncol Rep. 2007;  17 377-384
• 46 McNulty J, Nair J J, Codina C, Bastida J, Pandey S, Gerasimoff J, Griffin C. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids.  Phytochemistry. 2007;  68 1068-1074
• 47 Abou-Donia A H, Arner M E, Darwish F A, Kassem F F, Hammoda H AM, Abdel-Kader M S, Zhou B N, Kingston D GI. Two new alkaloids of the crinane series from Pancratium sickenbergeri.  Planta Med. 2002;  68 379-381
• 48 Christofori G. New signals from the invasive front.  Nature. 2006;  25 441-450
• 49 Mareel M M, Bracke M E, Van Roy F M, de Baetselier P. Molecular mechanisms in cancer invasion. Vol. II. Bertino JR Encyclopedia of cancer. San Diego: Academic Press; 1997 1072-1083
• 50 Schor S L, Schor A M, Winn B, Rushton G. The use of 3-dimensional collagen gels for the study of tumor-cell invasion in vitro: experimental parameters influencing cell-migration into the gel matrix.  Int J Cancer. 1982;  29 57-62
• 51 Bracke M E, Boterberg T, Bruyneel E A, Mareel M M. Collagen invasion assay. Brooks S, Schumacher U Metastasis research protocols. Totowa: Humana Press; 2001 81-89
• 52 Fisher C, Gilbertson-Beadling S, Powers E A, Petzold G, Poorman R, Mitchell M A. Interstitial collagenase is required for angiogenesis in vitro.  Dev Biol. 1994;  162 499-510
• 53 Klein C E, Dressel D, Steinmayer T, Mauch C, Eckes B, Krieg T, Blanke L. Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils.  J Cell Biol. 1991;  115 1427-1436
• 54 Vleminckxstarf K, Vakaet L, Mareel M, Fiersstarf W, Van Roystarf F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.  Cell. 1991;  66 107-119
• 55 Meyer M B, Bastholm L, Nielsen M H, Elling F, Rygaard J, Chen W, Obrink B, Bock E, Edvardsen K. Localisation of NCAM on MCAM‐B-expressing cells with inhibited migration in collagen.  APMIS. 1995;  103 197-208
• 56 Suwa T, Hinoda Y, Makiguchi Y, Takahashi T, Itoh F, Adachi M, Hareyama H, Imai K. Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells.  Int J Cancer. 1998;  76 377-382
• 57 Sandager M, Nielsen N D, Stafford G I, van Staden J, Jäger K J. Alkaloids from Boophane disticha with affinity to the serotonin transporter in rat brain.  J Ethnopharmacol. 2005;  98 367-370